Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Daunorubicin × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 58 Lymphoid 23 Myeloid 10 Classical hematology 6 Sarcoma 3 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 80 Paclitaxel 52 Trastuzumab 41 Tamoxifen 40 Doxorubicin 39 Specimen Handling 35 Docetaxel 35 Magnetic Resonance Spectroscopy 34 Radiotherapy 33 Taxes 30 Fluorouracil 26 Chemotherapy, Adjuvant 26 Carboplatin 24 Epirubicin 22 Biopsy 22 Filgrastim 21 Neoadjuvant Therapy 19 Methotrexate 19 aldesleukin 17 Peripheral Blood Stem Cell Transplantation 16 Bevacizumab 14 Anastrozole 14 exemestane 13 Lapatinib 13 veliparib 12 CMF regimen 12 sargramostim 11 Goserelin 11 Fulvestrant 11 Capecitabine 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00004207 2014-06-24

Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer

National Cancer Institute (NCI)

Phase 1 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡